Dose-volume analysis for respiratory toxicity in intrathoracic esophagealcancer patients treated with definitive chemoradiotherapy using extended fields

Journal of Radiation Research

Volumn 54, Issue 6, 2013, Pages 1085-1094

  Tanabe, Satoshi ^a,e   Myojin, Miyako ^a   Shimizu, Shinichi ^b   Fujino, Masaharu ^c   Takahashi, Hiroaki ^d   Shirato, Hiroki ^b   Ito, Yoichi M ^e   Ishikawa, Masayori ^e   Hosokawa, Masao ^d  

^a Keiyukai Sapporo Hospital   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO CANCER CENTER   (Japan)

^d Keiyukai Sapporo Hospital   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiation; Dose volume histogram; Dosimetric parameter; Esophageal cancer; Extendedfield; Radiation pneumonitis

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; DOSIMETRY; PATIENT MONITORING; RADIOTHERAPY;

2-GROUP; CHEMO RADIATIONS; DOSE-VOLUME ANALYSIS; DOSE-VOLUME HISTOGRAMS; DOSIMETRIC PARAMETER; ESOPHAGEAL CANCER; EXTENDED FIELD RADIOTHERAPY; EXTENDED FIELDS; EXTENDEDFIELD; RADIATION PNEUMONITIS;

CHEMORADIOTHERAPY;

PERU TOMATO MOSAIC VIRUS;

ARTICLE; CHEMORADIOTHERAPY; COMORBIDITY; DOSE-VOLUME HISTOGRAM; DOSIMETRIC PARAMETER; EPIDEMIOLOGY; ESOPHAGUS CANCER; ESOPHAGUS TUMOR; EXTENDED-FIELD; FEMALE; HUMAN; JAPAN; MALE; MORTALITY; PREVALENCE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RADIATION RESPONSE; RADIOMETRY; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICS; SURVIVAL RATE; THORAX TUMOR; TREATMENT OUTCOME; TUMOR VOLUME;

CHEMORADIATION; DOSE-VOLUME HISTOGRAM; DOSIMETRIC PARAMETER; ESOPHAGEAL CANCER; EXTENDED-FIELD; RADIATION PNEUMONITIS;

CAUSALITY; CHEMORADIOTHERAPY; COMORBIDITY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; JAPAN; MALE; PREVALENCE; RADIATION PNEUMONITIS; RADIOMETRY; RADIOTHERAPY DOSAGE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; THORACIC NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84888244031     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt047     Document Type: Article

References (13)

1. Barriger RB, Fakiris AJ, Hanna N et al. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel. Int J Radiat Oncol Biol Phys 2010;78:1381-6
2. Yorke ED, Jackson A, Rosenzweig KE et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:672-82
3. Tsujino K, Hirota S, Endo M et al. Predictive value of dosevolume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003;55:110-5
4. Hernando ML, Marks LB, Bentel GC et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001;51:650-9
5. Asakura H, Hashimoto T, Zenda S et al. Analysis of dosevolume histogram parameters for radiation pneumonitis afterdefinitive concurrent chemoradiotherapy for esophageal cancer. Radiother Oncol 2010;95:240-4
6. Zhu SC, Shen WB, Liu ZK et al. Dosimetric and clinical predictors of radiation-induced lung toxicity in esophageal carcinoma. Tumori 2011;97:596-602
7. Wang SL, Liao Z, Vaporciyan AA et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2006;64:692-9
8. Rodrigues G, Lock M, Souza DD et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer: a systematic review. Radiother Oncol 2004;71: 127-38
9. Tachibana M, Kinugasa S, Yoshimura H et al. Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg 2003;138:1383-9
10. Murshed H, Liu HH, Liao Z et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;58:1258-67
11. Yom SS, Liao Z, Liu HH et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-smallcell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2007;68:94-102
12. Fu W, Wang L, Zhou Z et al. Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma. World J Gastroenterol 2004;10:1098-102
13. Myojin M, Tanabe S, Hosokawa M et al. Does 3-D CRT plan become a clinical relevant factor to radiation pneumonitis risk in patients with esophageal cancer treated with definitive chemoradiotherapy? Int J Radiat Oncol Biol Phys 2011;81:S321